Institut de Neurobiologie de la Méditerranée
Parent institutions Aix-Marseille Université, Inserm
ROR: Yes
Works count: 6,086
Citations count: 296,000
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
2016 · Jordi Bruix, Shukui Qin, et al. · The Lancet
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
2015 · Marie Vétizou, Jonathan M. Pitt, et al. · Science
Excitatory actions of gaba during development: the nature of the nurture
2002 · Yehezkel Ben‐Ari · Nature reviews. Neuroscience